The Latest Breaking News from Exact Sciences

Exact Sciences, a large Cathie Wood holding, came in hot with double-digit sales growth. But EXAS stock reversed lower.

Cathie Wood's Ark Invest has big stakes in speculative plays such as Tesla and Coinbase. But even 2023's big winners are well off highs.

This stock holds a spot in maverick investor Wood's flagship fund, and analysts agree the cutting-edge diagnostics specialist has plenty of growth potential from current levels.

The maverick fund manager catches a lot of heat for her stock picks, but these three ARKK standouts are absolutely crushing the broader Nasdaq Composite so far in 2023.

Futures fell as Fitch downgraded the U.S. debt rating. AMD and ELF Beauty were big earnings movers late

Exact Sciences reported another quarter of strong growth, but screening sales missed whispered forecasts and EXAS stock plummeted Wednesday.

Cathie Wood has bet big on 10 stocks. Tesla stock has more than doubled in 2023, but it's not the strongest performer among Ark Invest's major holdings.

Exact Sciences said the company's next-generation Cologuard outperformed the original test. EXAS stock seesawed on the news.

The market for colon cancer screening is massive — and underserved. And that might be why EXAS stock is on an eight-month hot streak.

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Wednesday closed up +0.45%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.09%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.11%. Stock indexes Wednesday settled mixed, with the S&P 500...

Morning Markets June E-Mini S&P 500 futures (ESM2 3) this morning are up +0.37%, and June Nasdaq 100 E-Mini futures (NQM2 3) are up +0.45%. U.S. stock index futures this morning erased overnight losses and pushed higher after U.S. consumer prices eased in April. Bond yields also fell on the...